UNSPSC 85891568: High dose rate (hdr) brachytherapy of neck lymphatics using californium 252 (cf-252)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of neck lymphatics using californium 252 (cf-252). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D7139CZ

UNSPSC 85891568 High dose rate brachytherapy of neck lymphatics using californium 252 (Commodity) shows a mismatch between its nominal scope and current state and local procurement activity. The code's technical specificity—a specialized oncology radiation treatment modality—does not align with the single recent opportunity posted under it, which solicits temporary health professional staffing services across multiple ancillary clinical categories including audiology, cardiology, diagnostic imaging, gastroenterology, and therapy services, among others. The County of Santa Clara Health System issued a request for qualifications on July 7, 2026, for a non-exclusive, multiple-award qualified vendor pool with no guaranteed work volume, accepting proposals through October 7, 2026, for any or all of the thirteen eligible health professional categories. This classification mismatch suggests either a data-entry error in the underlying procurement record or a systematic misalignment in how this particular issuing body tags its opportunities.

The source contains no additional recent state and local opportunities under this code, no geographic spread across multiple jurisdictions, and no pattern of repeat buyers or sustained procurement activity. A single opportunity from one health system does not establish market demand or procurement momentum under this Commodity code. Business development activity should be treated as speculative unless and until additional qualified opportunities emerge under this code from other state, county, municipal, or health-system buyers.